Search Results

You are looking at 1 - 2 of 2 items for :

  • Insulin resistance and type 2 diabetes mellitus x
  • Refine by access: All content x
Clear All
Sandra K Szlapinski London, Ontario, Canada

Search for other papers by Sandra K Szlapinski in
Google Scholar
PubMed
Close
and
David J Hill Diabetes, Endocrinology and Metabolism, Lawson Health Research Institute, London, Ontario, Canada
Physiology and Pharmacology, Western University, London, Ontario, Canada

Search for other papers by David J Hill in
Google Scholar
PubMed
Close

and glucagon presence ( Mezza et al. 2014 ). Key to this process is a reduced expression of the gene Foxo1 by beta cells under hyperglycemic conditions ( Kitamura et al. 2005 ). The normalization of glycemia by insulin, GLP-1R agonists, or SGLT2

Restricted access
Margaret K Hahn Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada
Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada
Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
Banting & Best Diabetes Centre, Toronto, Ontario, Canada

Search for other papers by Margaret K Hahn in
Google Scholar
PubMed
Close
,
Adria Giacca Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada
Banting & Best Diabetes Centre, Toronto, Ontario, Canada
Department of Physiology, University of Toronto, Toronto, Ontario, Canada

Search for other papers by Adria Giacca in
Google Scholar
PubMed
Close
, and
Sandra Pereira Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Department of Physiology, University of Toronto, Toronto, Ontario, Canada

Search for other papers by Sandra Pereira in
Google Scholar
PubMed
Close

(GIP) and glucagon-like peptide 1 (GLP-1), respectively ( Campbell & Drucker 2013 , Reimann & Gribble 2016 ). Incretin hormones act on pancreatic β cells to potentiate insulin secretion ( Campbell & Drucker 2013 ). This ‘incretin effect’ is not

Open access